Caplin Point Laboratories Profit & Loss Annual

Trade
BSE: 524742 | NSE: CAPLIPOINT | ISIN: INE475E01026 | Sector: Biotechnology & Drugs
1,867.30 -0.65 (-0.03%)Updated : 30 Apr 2025
Fiscal Period2024202320222021
Period End DateMar 24Mar 23Mar 22Mar 21
Revenue 1,694.101,466.731,269.411,061.29
Total Revenue 1,694.101,466.731,269.411,061.29
Costof Revenue Total 762.91694.80581.85491.47
Gross Profit 931.19771.93687.56569.82
Selling/ General/ Admin Expenses Total 305.11266.98233.31186.89
Research Development 73.7263.1959.2753.69
Depreciation/ Amortization 53.4444.9946.9036.97
Total Operating Expense 1,195.181,069.96921.33769.02
Operating Income 498.92396.77348.08292.27
Interest Inc( Exp) Net- Non- Op Total 60.9849.8234.5419.73
Gain( Loss)on Saleof Assets -0.65-0.360.12-0.60
Other Net 5.185.123.082.23
Net Income Before Taxes 564.43451.35385.82313.62
Provisionfor Income Taxes 103.0174.3677.3762.19
Net Income After Taxes 461.42376.99308.45251.43
Minority Interest -4.33-0.73-8.61-9.16
Net Income Before Extra Items 457.09376.26299.84242.27
Net Income 457.09376.26299.84242.27
Income Availableto Com Excl Extra Ord 457.09376.26299.84242.27
Income Availableto Com Incl Extra Ord 457.09376.26299.84242.27
Diluted Net Income 457.09376.26299.84242.27
Diluted Weighted Average Shares 7.637.657.647.63
Diluted EPS Excluding Extra Ord Items 59.9049.1839.2631.74
DPS- Common Stock Primary Issue 5.004.504.003.00
Diluted Normalized EPS 59.9749.2239.2531.81
period Length 12.0012.0012.0012.00
period Type ----
Unusual Expense( Income) --0.000.00
Other Operating Expenses Total ---0.00
*All figures in crores except per share values
Recommended For You
Trending Stocks
12,207.00+359.95(3.04%)
1,863.70+39.85(2.18%)
1,952.40-112.60 (-5.45%)
8,635.70-453.60 (-4.99%)